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Abstract
Title: Gabapentin as an Adjunct to Decrease Opioid Consumption
Background: Pain is an individualized experience and controlling it can be a burden after
surgery. Opioids, or narcotics, are the staple of controlling pain after surgery, but there are
undesirable side effects. With the current opioid epidemic, many patients are also nervous about
becoming addicted to opioids. Multi-modal anesthesia is emerging in attempts to block the pain
pathway at different points and pain receptors. Gabapentin is an anti-seizure medication often
used as an analgesic for chronic neuropathies and migraines. By binding to the alpha-2 delta
subunit of the voltage-gated calcium channel, there is a decrease in excitatory neurotransmitters
such as glutamate and substance P. Since gabapentin works on the inflammatory pathway, it is
thought by giving preemptively, the pain pathway is disrupted, and post-operative opioid use
may decrease.
Purpose: The purpose of this independent project is to present a case report and provide a
comprehensive review of evidence-based literature to determine if gabapentin is effective in
reducing post-op opioid use.
Process: By accessing the University of North Dakota Health Sciences Library, a literature
search was completed through several databases including CINHAL, PubMed, Scopus, Medline
Complete, EBSCO, ClinicalKey, and HealthSource. Other related literature was acquired from
bibliographies of the initial articles found. All articles utilized were examined for their relation to
the topic.
Results: There were many meta-analysis and systematic reviews relating to gabapentin
administered pre-operatively and its effect on post-operative opioid use. Gabapentin was
consistently found to reduce opioid consumption at 24 hours post-operatively, as well as
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decrease pain scores, decrease nausea and improve patient satisfaction. Sedation was the only
side effect noted but did not occur with every patient. Gabapentin may be beneficial when
utilized with other non-opioid analgesics. Studies have not shown an optimal pre-op dose of
gabapentin, so more research needs to be completed.
Implications: Anesthesia providers strive to make patients as comfortable as possible and
gabapentin is showing promise in decreasing post-op opioid consumption, as well as improving
pain scores. With minimal side effects and drug interactions, gabapentin can safely be
administered pre-operatively.
Keywords: gabapentin, pain, narcotic, surgery
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Gabapentin as an Adjunct to Decrease Opioid Consumption
Background
Controlling pain after surgery continues to be a burden, despite the advances in
healthcare. Pain is a complex and individualized experience. There are different types of pain
that ensue when nociceptors are stimulated. Types of pain include somatic, visceral, neuropathic
and inflammatory. Somatic pain is considered sharp, localized pain, whereas visceral pain is
diffuse and vague. Neuropathic pain develops when damage to peripheral or central neural
structures occurs which causes abnormal processing. Lastly, inflammatory pain develops when
sensitization of the nociceptive pathway occurs from mediators at the site of inflammation. All
types of pain are perceived differently (Nagelhout & Elisha, 2018). Having the ability to block
pain perception or disrupt the way pain is processed should enable patients to heal faster, have
improved satisfaction, and essentially improve the cost of care (Penprase, Brunetto, Dahmani,
Janaqi Forthosffer, & Kapoor, 2015). Additionally, intense acute pain may lead to the
development of chronic pain, so ensuring pain is controlled post-op is a priority (Li, Guo, Li, &
Yang, 2017).
A growing concern in the country is opioid, or narcotic, addiction and many people fear
becoming addicted to narcotics after surgery. Adequate pain control is essential for all patients,
but especially for patients going home the same day of surgery. Narcotics are typically used for
moderate to severe pain, but common adverse side effects include nausea, vomiting, pruritis,
urinary retention, and respiratory depression (Liu, Liu, & Wang, 2017). If health care providers
can lower pain intensity, there may be less narcotics used, thus less side effects. Multi-modal
analgesia has been gaining popularity, even though the notion has been around for almost 100
years (Nagelhout & Elisha, 2018). By using different mechanisms of action to act on a variety of
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pain related receptors, a synergistic effect should occur and limit narcotic usage (Kremer &
Griffis, 2018). To help reduce post-operative pain and opiod use, gabapentin has been prescribed
pre-operatively by some anesthesia professionals.
Purpose
The purpose of this independent project is to present a case report of a patient undergoing
general anesthesia who received gabapentin pre-operatively and observe the amount of post-op
opioid used. Additionally, a review of literature was completed to gather evidence-based
research to determine if gabapentin is effective in decreasing post-op opioid consumption and
understand its mechanism of action.
Case Report
A 41-year-old, 177-cm, 97.3 kg, African-American female presented to the operating
room for a bilateral breast reduction. Past medical history included a N-STEMI, coronary artery
disease, hypertension, hyperlipidemia, and former smoker (quit a month before surgery). She had
no known medication allergies but had seasonal allergies. Current medications included
lisinopril, carvedilol, Lipitor, and melatonin. Prior anesthesia was for cardiac stent placement, in
which she had no complications. No known family history of anesthetic problems. Cardiac
echocardiogram showed an ejection fraction of 60% and her electrocardiogram (EKG) displayed
normal sinus rhythm with an old septal infarct. Pertinent labs included a negative pregnancy test,
hemoglobin 12.7 g/dL, hematocrit 38.7%, platelets 162,000 μ/L, potassium 4.3 mE/L, and
creatinine 0.86 m/dL.
Airway assessment revealed a Mallampati II, thyromental distance greater than three
fingerbreadths, mouth opening greater than three fingerbreadths, full intact dentition and full
neck range of motion. Nothing by mouth status was 10 hours. The patient was given an
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American Society of Anesthesiologists (ASA) physical class of 2. Pre-op vital signs were blood
pressure 133/90 mmHg, heart rate 63 beats per minute, respiratory rate 16 breaths per minute,
oxygen saturation 99% on room air, and temperature 36.6o Celsius. Her physical assessment
revealed regular heart tones and rhythm and clear bilateral breath sounds. Pre-op medications
included 600 milligrams (mg) gabapentin by mouth (PO), 1000 mg acetaminophen PO, and
3.125 mg carvedilol PO.
After being brought into the operating room via cart, the patient transferred herself onto
the operating table. Standard non-invasive monitors were placed on the patient, which included a
5-lead EKG, finger oximetry, a bi-spectral (BIS) index monitor, and a blood pressure cuff was
applied to her left calf due to the nature of the surgical procedure. An 18-gauge IV had been
placed in the day unit and Lactated Ringer’s infusing. A mask was gently placed over the
patient’s mouth and nose which had oxygen flowing at 10 liters per minute (lpm). At that time, 2
mg versed and a dexmedetomidine bolus of 38 micrograms (mcg) was administered
intravenously (IV). Pre-oxygenation was completed for three minutes and the patient had an endtidal oxygen saturation of 88%.
For induction, 200 mcg fentanyl, 40 mg lidocaine, and 200 mg propofol was administered
intravenously. Mask ventilation was easy without an oral adjunct. With no eyelid reflexes
present, the patient’s eyes were taped for corneal abrasion prevention and 50 mg rocuronium IV
was given. A Macintosh 3 blade was utilized for intubation, and a 7.0 mm endotracheal tube was
placed. Placement was confirmed with end-tidal CO2 and auscultation of bilateral breath sounds.
The tube was secured with tape. Desflurane was started and an end expiration concentration of
6.5% was achieved. The patient was placed on volume control ventilation with a tidal volume of
550 ml, rate of 9, and PEEP of 5. A nasopharyngeal temperature probe was placed for
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continuous temperature monitoring during the procedure. The patient’s heart rate increased to the
140’s shortly after induction. BIS monitor showed adequate depth of anesthesia at 35%, with 0.9
MAC. An additional 150 mcg fentanyl IV was administered with no change. At that time, 5 mg
of metoprolol IV was given, and the heart rate decreased to 80 beats per minute. An additional
16 gauge IV was placed in the right hand and secured with a transparent dressing.
During maintenance, desflurane was continued at an end expiration concentration of
6.5% and a dexmedetomidine continuous IV infusion was at 0.4 mcg/kg/hr. A lower body air
warmer was initiated. Prior to incision, 2 g Ancef was given IV. Intravenous anti-emetics
administered after induction included 4 mg ondansetron and 4 mg dexamethasone. A total of 25
mg of ephedrine was given intravenously to maintain systolic blood pressure greater than 100
mmHg and mean arterial pressure (MAP) greater than 65 mmHg. An additional 50 mcg of IV
fentanyl was given during the case.
Close to the end of the procedure, neuromuscular blockade was checked with a train of
four nerve stimulator. A 4/4 response was noted on the orbicularis oculi muscle. To ensure full
neuromuscular blockade antagonism, 3 mg of IV neostigmine was given. To prevent muscarinic
side effects of neostigmine, 0.2 mg of IV glycopyrrolate was administered. Procedure duration
was four hours. A total of 2150 ml of Lactated Ringer’s was administered during the case and an
additional dose of 4 mg IV ondansetron was given. Blood loss was estimated at 200 ml and urine
output was 985 ml.
Once the dressings were placed and the patient was adequately reversed, desflurane was
discontinued, 100% FiO2 was administered with the oxygen flow rate increased to 8 lpm. A
subglottal suction catheter was introduced, and excess sputum removed. Once the patient had
adequate spontaneous ventilation volumes of 4 ml/kg, opened her eyes, and squeezed hands to
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command, the endotracheal tube was removed. Four liters of oxygen was applied via nasal
cannula. The patient was transferred to the post-anesthetic recovery room (PACU) via cart and
patient stated she was comfortable. Ten minutes after arrival to the PACU, another 4 mg of
ondansetron was given IV for nausea. An hour later, 50 mcg IV fentanyl was given for 5/10 pain.
After an hour and a half in the recovery room, 10 mg oxycodone was administered orally. The
patient’s pain was well-controlled at 3/10 and discharged home 2 hours and 15 minutes after
PACU arrival.
Literature Search
PICO Question
Not every anesthesia provider administers gabapentin pre-operatively and its use remains
controversial in controlling post-op pain. To simplify finding clinically relevant literature, a
PICO question was formed. PICO stands for population (P), intervention (I), comparison (C),
and outcome (O). By constructing a PICO question, answers to health care related issues are
sought by providing an effective search of evidence-based literature (Stillwell, FineoutOverhold, Melnyk, & Williamson, 2010). The PICO question constructed is: among adult
patients undergoing elective surgery (P), does the administration of gabapentin pre-op (I)
compared to those not receiving gabapentin (C) have a decrease in opioid use post-op (O)?
Prior to the literature search, inclusion and exclusion criteria was determined. Articles
reviewed were evaluated using Melnyk and Fineout-Overholt’s Evidence-based Practice in
Nursing and Healthcare: A Guide to Best Practice (Stillwell et al., 2010). This provides a guide
to levels of hierarchy in nursing research. Study strengths are illustrated by a pyramid and allows
the determination of the strength of a recommendation. Level I is considered the highest level
and includes systematic reviews of randomized controlled studies, as well as meta-analysis
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reviews. In order to find the appropriate randomized control trials, the researchers filter the
results. The lowest level is VII, which is evidence from reports by expert committees. The
highest level of evidence reduces bias and provides strength to the recommendations. Most of the
literature utilized for this project was level I.
Databases
After the PICO question was formulated, The University of North Dakota Health
Sciences Library was accessed to search several databases for pertinent literature. Databases
searched included CINHAL Complete, Medline Complete, EBSCO Megafile, HealthSource:
Nursing/Academic Edition, ClinicalKey, Scopus and PubMed. These databases were chosen
because they cover nursing research, as well as medical research. Both need to be reviewed, as
anesthesia is viewed from the nursing and medical standpoint.
Vocabulary and Limits
To obtain relevant articles, key words from the PICO question were utilized. The search
included the key words gabapentin, pain, narcotic, and surgery. Keywords were used together
when searching the databases, as the results when only two or three keywords were combined
had an overwhelming number of articles. The searches were limited to full text review, metaanalysis, and randomized control trial articles in journals within the past five years, human
subjects, and the English language.
The first search was performed using Scopus. There was an extensive number of articles
found related to the use of gabapentin as an adjunct for pain control. This proved to be a
limitation of the search as a total of 65 related articles were found. After review of relevant
articles, the similar articles link was accessed. This resulted in fewer articles, but the articles did
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not review administration of gabapentin alone. For that reason, none of the articles in Scopus
were utilized.
PubMed generated 21 articles and ClinicalKey resulted in 22 articles. Several articles in
those searches were duplicates, but six articles provided high quality reviews relevant to this
independent project. The National Library of Medicine, which includes CINHAL, Medline,
EBSCO, and HealthSource, generated 16 articles. From this database, four of the articles were
relevant to the topic of gabapentin and the reduction of opioid use.
Another search was conducted utilizing PubMed to gain a better understanding of the
mechanism of action of gabapentin. Keywords used were gabapentin, mechanism of action, and
pain. Limitations included articles within the last five years and full text articles. A total of 471
articles were found. After reviewing the first displayed articles, an informative article’s similar
articles link was accessed. This yielded 44 results. Four articles provided general information on
gabapentin, as well as the advantages of controlling pain. This information was utilized for
explaining the background and pain pathway of gabapentin.
Review of Literature
Pain Pathway
In order to understand how to modulate the pain pathway, a basic understanding of the
pathway is necessary. A nociceptor is a sensory neuron or first order neuron. When a noxious
stimulus, such as a surgical incision, occurs on peripheral nociceptors, it is changed into an
action potential. Simultaneously, chemical mediators and excitatory neurotransmitters are
released, such as Substance P, glutamate, bradykinin, histamine, serotonin, prostaglandin,
cytokines, and calcitonin gene-related peptide causing an inflammatory response. The action
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potential is transmitted through first order neurons to the dorsal root ganglia of the spinal cord,
generally by fast A-delta fibers or slow C-fibers (Nagelhout & Elisha, 2018).
Transmission of the pain impulse travels through the ascending pathway, also referred to
as the spinothalamic tract or second order neurons, which synapse with third order neurons in the
brain. Processing and pain perception occur in several areas of the brain, including the thalamus,
reticular formation, and somatosensory area of the cerebral cortex. After processing, a response
is transmitted back to the spinal cord through the descending pathway. The descending pathway
modulates the ascending pathway through the periaqueductal gray area, nucleus raphe magnus,
and locus coeruleus by attempting to suppress pain transmission that occurs in the dorsal horn of
the spinal cord (Nagelhout & Elisha, 2018).
Sensitization of nociceptors occurs both in the peripheral and central pathway
(Butterworth, Mackey, & Wasnick, 2013). This results in hyperalgesia, or increased sensitivity to
pain, and allodynia, or a normally non-painful stimulus becomes painful (Butterworth et al.,
2013). There are many excitatory and inhibitory neurotransmitters in the pain pathway.
Excitatory neurotransmitters, which were aforementioned, make pain more intense, whereas
inhibitory neurotransmitters try to block pain (Nagelhout & Elisha, 2018). Neurotransmitters
produce their effect when they act on specific receptors.
Gabapentin
Gabapentin was first developed as an anti-seizure medication but has an off-label use for
chronic pain, such as neuropathies and migraines (Rivken & Rivken, 2014). Structurally,
gabapentin is a gamma-aminobutyric acid (GABA) analog but does not bind to GABA receptors.
The exact mechanism of action for reducing pain is unknown, but research is providing a better
understanding of how the medication works. The most widely accepted theory is that gabapentin
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modulates the pre-synaptic alpha-2 delta sub-unit of voltage-gated calcium channels (Rivkin &
Rivkin, 2014).
Once gabapentin is bound to the calcium channels in the nerve terminals, calcium is
unable to enter the neuron, which inhibits the release of neurotransmitters such as glutamate and
substance P (Alles et al., 2017). Both these substances participate in pain promotion and wind-up
pain. Glutamate is an excitatory neurotransmitter that acts on the N-methyl-D-aspartate (NMDA)
receptor (Nagelhout & Elisha, 2018). Once the NMDA receptor becomes activated, nitric oxide
increases and excitatory amino acids are released. These cause sharp, fast pain (Butterworth et
al., 2013). Substance P is a peptide released from afferent C-fibers and is involved with
inflammatory pain. When an incision is made, an inflammatory response begins. Substance P
causes mast cell degranulation and histamine release. This process also activates peripheral
nociceptors. Plasma protein extravasation occurs causing vasodilation, edema and additional
release of bradykinin (Barrett, Barman, Brooks, & Yaan, 2019).
Studies have shown gabapentin exerts its effects at the peripheral nerve terminals, as well
as the spinal cord, thalamus and cortical level (Alles & Smith, 2019). Synaptic transmission is
attenuated by primary afferent neurons and second order neurons in the spinal dorsal horn by
decreasing glutamate release (Alles et al., 2017). With less glutamate, the NMDA receptor is
unable to be activated and the transmission from peripheral sensory neurons to second order
neurons is interrupted (Tomic, Pecikoza, Micov, Vuckovic, & Stepanovic-Petrovic, 2018). The
excitatory drive has also been seen to decrease in the post-synaptic excitatory currents in the
substantia gelatinosa (Alles et al., 2017; Tomic et al., 2018). By affecting these areas, the
brainstem and medulla alter the descending nociceptive processing at the spinal level and
promote the supraspinal modulation of pain (Alles & Smith, 2019). Depression of the reticular
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formation and limbic system, which deal with the emotional experience of pain, has also been
seen (Alles et al., 2017).
By exerting its effects in the dorsal horn of the spinal cord to reduce substance P,
gabapentin prevents peripheral and central sensitization when administered prior to insult (Tomic
et al., 2018). In addition, the inflammatory pain was decreased to a greater extent in a
preventative setting versus when the inflammatory process had already begun (Tomic et al.,
2018). This was evidenced by a decrease in edema and neutrophil infiltration to the area of
incision (Tomic et al., 2018).
Pre-operative Gabapentin
Numerous studies have been completed with gabapentin administered pre-operatively
and the observation of post-op opioid consumption. With many randomized control trials
completed, there have been several systematic reviews and meta-analysis of administration of
pre-op gabapentin and the relationship it has with post-op opioid use, pain scores, patient
satisfaction and adverse side effects.
Alayed, Alghanaim, Tan, and Tulandi (2014) completed a systematic review of 14
randomized controlled trials of patients undergoing abdominal hysterectomies where some
women received pre-op gabapentin, and others received a placebo. A total of 900 patients were
included. Cumulative morphine doses were compared post-op, as well as pain scores based on
the visual analog scale (VAS). A significant reduction in opioid use was found with the
gabapentin group at 24 hours. Patients who received gabapentin also had a decrease in their VAS
score. An interesting find was the addition of several doses of gabapentin administered postoperatively had no significant effect on VAS scores, deciding that gabapentin is favorable for
pre-op administration (Alayed et al., 2014).
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Steinberg et al. (2017) also reviewed randomized control trials of abdominal
hysterectomies and the use of gabapentin preemptively. The researchers assessed gabapentin
solely, as well as combined with other pre-operative analgesics. Their systematic review
determined the use of gabapentin with the addition of acetaminophen used fewer narcotics than
gabapentin alone. This conclusion supports the theory of analgesics having a synergistic effect
on pain control. Satisfaction scores among those who received gabapentin as an intervention
were higher than those who did not receive gabapentin. The length of stay was no different
between the control and intervention group.
Other systematic reviews and meta-analysis have been completed which also show
patients who receive gabapentin pre-operatively have a reduction in opioid use, a decrease in
pain scores, and an increase in patient satisfaction (Doleman et al., 2015; Li et al., 2017; Mao,
Wu, & Ding, 2016). Doleman et al. (2015) reviewed 133 studies which had a large amount of
heterogeneity in surgeries but concluded the type of surgery was not a factor in opioid
consumption but the subjective experienced pain by the patient. In other words, the effect of
gabapentin post-op was independent of the surgical procedure. Not only did gabapentin decrease
post-op opioid consumption and improve pain scores, but chronic pain at three months post-op
was reduced (Doleman et al., 2015).
Gabapentin was found to be less effective when administered with spinal anesthesia
(Doleman et al., 2015). This finding was consistent with Mao, Wu, and Ding’s (2016) review of
patients undergoing total hip arthroplasties where some patients received spinal anesthesia with
gabapentin and others received only spinal anesthesia. There was no difference in VAS scores at
rest or mobilization between patients who received gabapentin pre-op and those who did not
(Mao, Wu, & Ding, 2016).
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Not only is spinal anesthesia common with hip arthroplasties, but also with total knee
arthroplasties. A meta-analysis performed by Zhai, Song, and Liu (2016) analyzed six clinical
studies, which included 769 patients who received gabapentin pre-operatively, and observed its
effects. Unfortunately, the results were not broken down into the type of anesthesia administered.
A combination of spinal and general anesthesia was used. Results showed a decrease in post-op
opioid use for those who received gabapentin, as well as a decrease in VAS scores (Zhai, Song,
& Liu, 2016). Although opioid use was lower, there was no difference when patients were
mobilized (Zhai, Song, & Liu, 2016).
Li et al. (2017) looked at 12 randomized control trials which included 938 patients
undergoing laparoscopic cholecystectomies and compared opioid usage between those who
received gabapentin pre-op and those who did not. Opioid consumption was reduced, as well as
pain scores both at rest and with mobilization. With a lower pain level, patients may mobilize
sooner and ultimately have an earlier discharge, decreasing the cost of care (Li et al., 2017). One
item which makes this meta-analysis unique is researchers observed the dose-effect relationship
between gabapentin and VAS scores. A positive correlation was found between the two. As the
dose of gabapentin increased, the VAS scores improved (Li et al., 2017).
A comparative study including 83 women was completed to evaluate outcomes of
patients undergoing bilateral breast reduction surgery using a multi-modal, narcotic free
approach with IV sedation versus a traditional general anesthetic with opioids (Parsa et al.,
2017). Although this study does not specifically discuss gabapentin given alone pre-operatively,
it does include gabapentin as part of a multi-modal approach to analgesia. The multi-modal
approach utilized celecoxib and gabapentin pre-operatively and acetaminophen post-operatively
for pain control. Both groups received lidocaine as the local anesthetic intra-operatively.
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Surprisingly, the opioid-free group used less narcotics in the recovery room, had less incidence
of nausea, and had quicker discharge times. The theory behind the results is the body’s natural
opioids, beta-endorphins, are stimulated with incision which help with post-op pain control.
Beta-endorphins have been said to be 18 to 33 times more potent than opioids (Parsa et al.,
2017). There were several limitations to the study but shows consistency with systematic review
results demonstrating gabapentin can reduce post-op narcotic use.
Discussion
A common theme among the systematic reviews and meta-analysis was gabapentin
reduced post-op opioid use in the first 24 hours, decreased pain scores, and decreased nausea.
The only major side effect associated with administration of gabapentin was sedation (Alayed et
al., 2014; Doleman et al., 2015). This may be beneficial, as pre-operative anxiety may be
reduced. The optimal dose is yet to be determined as gabapentin dosing ranged from 300 mg to
1200 mg PO in the randomized control trials. Li et al. (2017) found higher doses were superior to
low doses of gabapentin, but there also was a positive correlation between the dose and sedation.
After receiving 600 mg of PO gabapentin an hour and a half before surgery, the patient
presented to the operating room fully awake and did not complain of being drowsy but did feel
relaxed. Literature states to use a “normal” amount of narcotic intra-op (Steinberg et al., 2017);
therefore, narcotic use during surgery was not decreased due to pre-op gabapentin
administration. In the recovery room, she only needed a single dose of IV opioid. It is unknown
what she was prescribed at discharge, but studies reviewed only observed IV consumption, not
oral. She did, however, require an additional dose of ondansetron shortly after PACU arrival
even though a dose was given with emergence. She was discharged home quickly, which
indicates she should have been comfortable, both with her pain and nausea.
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Providing adequate pain relief is a priority for anesthesia professionals. Through the
review of literature, the recommendation is 600 mg of gabapentin PO be administered two hours
pre-op to those undergoing elective surgeries. Since the use of multi-modal analgesia has
synergistic effects, the addition of 1000 mg of acetaminophen PO administered pre-op is also
recommended. Gabapentin is not metabolized by the liver, which minimizes drug-drug
interactions (Barrett et al., 2019). Assessment of kidney function is necessary as the drug is
excreted by the kidneys unchanged. If one’s creatinine is elevated, a 300 mg PO dose may be
administered, or gabapentin could be abandoned altogether.
In order to determine if a recommendation is strong or not, the Strength of
Recommendation Taxonomy scale was utilized. The quality, quantity, and consistency of
evidence is evaluated, and patient-oriented outcomes are emphasized (Ebell et al., 2004). An Alevel grade is the best and is based on consistent evidence (Ebell et al., 2004). The lowest grade
is a C-level grade, which can be an opinion, usual practice, or consensus based (Ebell et al.,
2004). After review of the strength of recommendation algorithm, the administration of
gabapentin pre-op has patient-oriented evidence and systematic reviews have shown consistent
results. This recommendation would receive an A grade. The research for multi-modal analgesia
is still emerging and one review article suggested the addition of either acetaminophen or
celecoxib with gabapentin (Steinberg et al., 2017). Based on this conclusion, the strength of
recommendation would receive a grade of C. The research did not specifically discuss
gabapentin in relation to kidney function, so this recommendation would also receive a C grade.
With the implementation of administering pre-op gabapentin, the hope is to reduce the
amount of opioid use post-op. Since gabapentin has shown to also reduce pain scores after
surgery, patient satisfaction increases. Healing ultimately may occur quicker, reducing the
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number of infections and decreasing the cost of care. In today’s healthcare, all those factors are
important, and hospitals have been attempting to improve all of them.
Conclusion
After an extensive review of literature, it appears gabapentin administered preoperatively decreases the amount of opioids used post-operatively. Along with the decrease of
opioids, pain scores were lowered, adverse side effects were reduced, and patient satisfaction
improved. More research with larger sample sizes needs to be completed to determine the
optimal pre-op dose. With the current opioid epidemic and patients fear of becoming addicted to
opioids, research has shown gabapentin to be effective in decreasing post-op narcotic use, which
is beneficial for patients undergoing surgeries.

GABAPENTIN

20

References
Alayed, N., Alghanaim, N., Tan, X., & Tulandi, T. (2014). Preemptive use of gabapentin in
abdominal hysterectomy: a systematic review and meta-analysis. Obstetrics &
Gynecology, 123(6), 1221-1229.
Alles, S., Bandet, M. V., Eppler, K., Non, M. C., Winship, I. R., Baker, G., Ballanyi, K., &
Smith, P. A. (2017). Acute anti-allodynic action of gabapentin in dorsal horn and primary
somatosensory cortex: correlation of behavioural and physiological data.
Neuropharmacology, 113(Part A), 576-590. Doi:
https://doi.org/10.1016/j.neuropharm.2016.11.011
Alles, S., & Smith, P. (2019). Comparison of ex vivo and in vivo actions of gabapentin in
superficial dorsal horn and the role of extra-spinal sites of drug action. Neuroscience
Letters, 694(16), 148-153. Doi: https://doi.org/10.1016/j.neulet.2018.11.050
Barrett, K. E., Barman, S. M., Brooks, H. L., & Yaan, J. J. (2019). Somatosensory
Neurotransmission: touch, pain, and temperature. Ganong’s Review of Medical
Physiology 26e. New York, NY: McGraw-Hill. Retrieved from
https://accessmedicine.mhmedical.com.ezproxylr.med.und.edu/content.aspx?bookid=252
5&sectionid=204291198
Butterworth, J. F., Mackey, D. C., & Wasnick, J. D. (2013). Morgan & Mikhail’s clinical
anesthesiology (5th ed.). United States: McGraw-Hill Companies, Inc.
Doleman, B., Heinink, T. P., Read, D. J., Faleiro, R. J., Lund, J. N., & Williams, J. P. (2015). A
systematic review and meta-regression analysis of prophylactic gabapentin for
postoperative pain. Anaesthesia, 70, 1186-1204. Doi: 10.1111/anae.13179
East Carolina University Libraries. (2018). Evidence-based practice for nursing: evaluating the

GABAPENTIN

21

evidence. Retrieved from libguides.ecu.edu/c.php?g=17486&p=97640
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J., Ewigman, B., & Bowman, M.
(2004). Strength of recommendation taxonomy (SORT): a patient-centered approach to
grading evidence in the medical literature. American Family Physician, 69(3), 548-556
Gallagher-Ford, L., Fineout-Overholt, E., Mazurek Melnyk, B., & Stillwell, S. B. (2011).
Implementing an evidence-based practice change. American Journal of Nursing, 111(3),
54-61.
Kremer, M. J., & Griffis, C. A. (2018). Evidence-based use of nonopioid analgesics. American
Association of Nurse Anesthetists, 86(4), 321-327.
Li, S., Guo, J., Li, F., Yang, Z., Wang, S., & Qin, C. (2017). Pregabalin can decrease acute pain
and morphine consumption in laparoscopic cholecystectomy patients. Medicine, 96(21),
1-12. doi: 10.10971MD.0000000000006982
Liu, B., Liu, R., & Wang, L. (2017). A meta-analysis of the preoperative use of gabapentinoids
for the treatment of acute postoperative pain following spinal surgery. Medicine, 96(37),
1-11. doi: 10.1097/MD.0000000000008031
Mao, Y., Wu, L., & Ding, W. (2016). The efficacy of preoperative administration of
gabapentin/pregabalin in improving pain after total hip arthroplasty: a meta-analysis.
BMC Musculoskeletal Disorders, 17(373), 1-11. Doi: 10.1186/s12891-016-1231-4
Nagelhout, J. J., & Elisha, S. (2018). Nurse anesthesia (6th ed.). St. Louis, MO: Elsevier.
Parsa, F. D., Cheng, J., Stephan, B., Castel, N., Kim, L., Murariu, D., & Parsa, A. (2017).
Bilateral breast reduction without opioid analgesics: a comparative study. Aesthetic
Surgery Journal, 37(8), 892-899. Doi: 10.1093/asj/sjx038
Penprase, B., Brunetto, E., Dahmani, E., Janaqi Forthosffer, J., & Kapoor, S. (2015). The

GABAPENTIN

22

efficacy of preemptive analgesia for postoperative pain control: a systematic review of
the literature. Association of Perioperative Nurses, 101(1), 94-105. doi:
10.1016/j.aorn.2014.01.030
Rivkin, A., & Rivkin M. A. (2014). Perioperative nonopioid agents for pain control in spinal
surgery. American Journal of Health-System Pharmacy, 71(21), 1845-1857. doi:
10.2146/ajhp130688
Steinberg, A. C., Schimpf, M. O., White, A. B., Mathews, C., Ellington, D. R., Jeppson, P., . . .
Murphy, M. (2017). Preemptive analgesia for postoperative hysterectomy pain control:
systematic review and clinical practice guidelines. American Journal of Obstetrics &
Gynecology, 3(13), 303-311. doi: http://dx.doi.org/10.1016/j.ajog.2017.03.013
Stillwell, S. B., Fineout-Overholt, E., Melnyk, B. M., & Williamson, K. M. (2010). Asking the
clinical questions: A key step in evidence-based practice. American Journal of Nursing,
110(3), 58-61.
Tomic, M., Pecikoza, U., Micov, A., Vuckovic, S., & Stepanovic-Petrovic, R. (2018).
Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical
evidence. Pharmacology & Therapeutics, 192, 42-64. Doi: 10.1016/j.pharmthera.2018.0
Zhai, L, Song, Z, & Liu, K. (2016) The effect of gabapentin on acute postoperative pain in
patients undergoing total knee arthroplasty: a meta-analysis. Medicine (Baltimore),
95(20), 1-9

GABAPENTIN

23

Appendix A

Introduction
•
•

Gabapentin as an Adjunct to
Decrease Opioid Consumption

Pain control after surgery is a burden
Types of pain
–
–
–
–

•

Importance of pain control
–
–
–
–
–

Bethany Myhre, SRNA

Somatic
Visceral
Neuropathic
Inflammatory
Faster healing
Decrease infections
Improved patient satisfaction
Decrease chance of chronic pain
Decrease healthcare costs

•

Opioids

•

Multi-modal analgesia

– Moderate to severe pain
– Adverse side effects

– Pre-op gabapentin

Case Information

Pre-operative Evaluation

•
•
•
•
•
•

• Past Medical History

Bilateral Breast Reduction
41-year-old
97 kg
Female
ASA 2
NKDA

–
–
–
–
–

N-STEMI
Coronary artery disease
Hypertension
Hyperlipidemia
Former smoker

• Surgical History
– Cardiac stent placement

– Seasonal allergies

Pre-operative Evaluation

Anesthetic Course

• Pertinent labs

• Medications

–
–
–
–
–
–

Negative pregnancy test
Hgb 12.7 g/dL
Hct 38.7%
Plt 162,000 μ/L
Potassium 4.3 mE/L
Cr 0.86 m/dL

• EKG
– NSR with old septal infarct

• ECHO
– EF 60%

• Airway Evaluation
– Mallampati II
– TMD > 3 fingerbredths
– Mouth opening > 3
fingerbredths
– Full intact dentition
– Full neck range of motion

• NPO 10 hours

• Current Medications
– Lisinopril, carvedilol,
Lipitor, melatonin

• Pre-op VS
–
–
–
–
–

BP 133/90 mmHg
HR 63/min
RR 16/min
SpO2 97% RA
T 36.6o C

– Pre-op: 600 mg gabapentin, 1000 mg acetaminophen,
3.125 mg carvedilol
– Induction: 2 mg versed, 38 mcg dexmedetomidine
bolus over 10 minutes, 200 mcg fentanyl, 40 mg
lidocaine, 200 mg propofol, 50 mg rocuronium
– Maintenance: desflurane end expiration concentration
of 6.5%, 0.4 mcg/kg/hr dexmedetomidine infusion, 4
mg ondansetron, 4 mg dexamethasone, 2 g cefazolin

• General anesthetic
– Duration
– No nerve monitoring
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Intraoperative Issues

PACU

• After Induction:

• Medications

• Emergence

– HR increased to 140’s

– 3 mg neostigmine
– 0.2 mg glycopyrrolate
– 4 mg ondansetron

• 150 mcg fentanyl
• 5 mg metoprolol

– Additional 16 g IV

• Totals

• Maintenance

–
–
–
–

– BP decreased
• Total of 25 mg ephedrine

LR 2150 ml
EBL 200 ml
UO 985 ml
Duration 4 hours

– 4 mg ondansetron
– 50 mcg fentanyl for 5/10 pain
– 10 mg oxycodone

• Discharged after 2 hours and 15 minutes postop
• Pain 3/10

Pain Pathway

Gabapentin

• First Order Neurons

• Anti-seizure medication

– Nociceptor

– Used for chronic pain, neuropathies, and migraines

• Transmitted by A-delta
or C fibers

• GABA analog, but does not bind
to GABA receptors
• Mechanism of action

• Second Order Neurons
– Spinothalamic tract

• Third Order Neurons
– Processing and pain
perception
– Thalamus, reticular
formation, and
somatosensory area of
the cerebral cortex

– Modulates pre-synaptic alpha-2
delta sub-unit of voltage-gated
calcium channels
– Inhibits release of neurotransmitters

• Descending pathway
– Periaqueductal gray area,
nucleus raphe magnus,
and locus coeruleus

• Glutamate and Substance P
https://i.pinimg.com/originals/2b/16/2a/2b162aafbda2866129f1abf41aa6c2a9.jpg

(Nagelhout & Elisha, 2018)

(Alles et al. 2017; Barrett, Barman, Brooks, & Yaan, 2019; Nagelhout & Elisha 2018; Rivken
& Rivken, 2014)
(Image: https://accessmedicine-mhmedical-com.ezproxylr.med.und.edu/ViewLarge.aspx
?figid =175219023&gbosContainerID=0&gbosid=0&groupID=0)

Gabapentin cont.

Pre-op Gabapentin

• Where gabapentin exerts effects

• Abdominal Hysterectomy

– Peripheral nerve terminals
– Spinal cord
– Thalamus
– Cerebral cortex

• Inflammatory
Inhibition
– Pain decreased more in preventative setting
(Alles & Smith, 2019; Alles et al., 2017; Tomic, Pecikoza, Micov, Vuckovic, &
Stepanovic-Petrovic, 2018. Image: Katzung, Kruidering-Hall, & Trevor, 2019)

– Alayed, Alghanaim, Tan, & Tulandi (2014)
• Patients who received gabapentin pre-op had significant
reduction in post-op opioid use and decrease in visual
analog scale (VAS) in first 24 hours
• Additional doses of gabapentin post-op had no significant
effect on VAS scores

– Steinberg et al. (2017)
• Gabapentin with the addition of acetaminophen used less
narcotics than gabapentin alone
• Satisfaction scores among those who received gabapentin
were higher than those who did not receive gabapentin
• No difference in length of stay
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Pre-op Gabapentin cont.

Pre-op Gabapentin cont.

• Doleman et al. (2015)

• Li et al. (2017)

– Reduction in opioid use post-op, decrease in pain scores, and
increased patient satisfaction
– Type of surgery was not a factor in the patient’s pain experience
– Chronic pain at three months was reduced
– Less effective with spinal anesthesia

• Mao, Wu, & Ding (2016)
– Reviewed total hip arthroplasties
• No difference in VAS scores at rest or with mobilization

• Zhai, Song, & Liu (2016)
– Reviewed total knee arthroplasties
• Combination of spinal and general anesthesia with pre-op gabapentin
• Decrease in post-op opioid use and VAS scores for those who received
gabapentin
• No difference in VAS scores when patients mobilized

– Reviewed laparoscopic cholecystectomies
• Reduction in post-op opioid use and pain scores at rest and
at mobilization
• Observed dose-effect relationship between gabapentin and
VAS scores
– As dose increased, VAS scores improved

• Parsa et al. (2017)
– Small comparative study of 83 women undergoing
bilateral breast reduction surgery
• Narcotic free approach vs. traditional GA approach
• Opioid free group used less opioids in the recovery room,
less nausea, and quicker discharge times

Recommendations

Conclusion

• 600 mg gabapentin administered 2 hours preop for elective surgeries
• 1000 mg acetaminophen pre-op
• Reduced dose of 300 mg or no gabapentin
with patients with kidney problems

• Patient received 600 mg gabapentin 1 ½ hours
pre-op
– No complaints of drowsiness, but felt relaxed
– Normal amount of opioids given intra-op
– Needed single dose of IV fentanyl post-op
– Discharged just over 2 hours post-op

(Barrett et al. 2019)

Conclusion
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